ID: ALA4851123

Max Phase: Preclinical

Molecular Formula: C14H17N3O4

Molecular Weight: 291.31

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc(COCCn2c([N+](=O)[O-])cnc2C)cc1

Standard InChI:  InChI=1S/C14H17N3O4/c1-11-15-9-14(17(18)19)16(11)7-8-21-10-12-3-5-13(20-2)6-4-12/h3-6,9H,7-8,10H2,1-2H3

Standard InChI Key:  YZVDYSHZQARKRJ-UHFFFAOYSA-N

Associated Targets(non-human)

Pancreatic alpha-amylase 211 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 291.31Molecular Weight (Monoisotopic): 291.1219AlogP: 2.33#Rotatable Bonds: 7
Polar Surface Area: 79.42Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.03CX LogP: 1.75CX LogD: 1.75
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.44Np Likeness Score: -1.56

References

1. Patel OPS, Jesumoroti OJ, Legoabe LJ, Beteck RM..  (2021)  Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.,  210  [PMID:33234343] [10.1016/j.ejmech.2020.112994]

Source